Piper Jaffray Downgrades Auspex Pharmaceuticals To Neutral
March 31, 2015 at 08:55 AM EDT
Analysts at Piper Jaffray downgraded Auspex Pharmaceuticals, Inc. (NASDAQ: ASPX) from Overweight to Neutral. The price target for ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.